Neuland Laboratories Shares outstanding
What is the Shares outstanding of Neuland Laboratories?
The Shares outstanding of Neuland Laboratories Limited is 12.830M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with shares outstanding similar to Neuland Laboratories
- Elfato has Shares outstanding of 12.799M
- SWK has Shares outstanding of 12.809M
- Kina Petroleum has Shares outstanding of 12.817M
- Assure has Shares outstanding of 12.819M
- ALSO AG has Shares outstanding of 12.823M
- Capstone Turbine has Shares outstanding of 12.824M
- Neuland Laboratories has Shares outstanding of 12.830M
- Grow Capital has Shares outstanding of 12.839M
- Lotus Chocolate has Shares outstanding of 12.841M
- Esso has Shares outstanding of 12.855M
- Billington Plc has Shares outstanding of 12.861M
- Severn Bancorp Inc has Shares outstanding of 12.864M
- Rex Resources Corp has Shares outstanding of 12.869M